Does epigenetic drift contribute to age-related increases in breast cancer risk?

Epigenomics

Volumn 6, Issue 4, 2014, Pages 367-369

  Langevin, Scott M ^a   Pinney, Susan M ^a   Leung, Yuet Kin ^a   Ho, Shuk Mei ^a  

^a UNIVERSITY OF CINCINNATI COLLEGE OF MEDICINE   (United States)

Author keywords

aging; DNA methylation; epigenetic drift; promoter methylation; stochastic selection

Indexed keywords

AGE; BREAST CANCER; CANCER PREVENTION; CANCER RISK; CELL PROLIFERATION; DNA METHYLATION; EPIGENETICS; GENE EXPRESSION; GENOMIC INSTABILITY; HISTONE MODIFICATION; HUMAN; PROMOTER REGION; REVIEW; TUMOR SUPPRESSOR GENE; BREAST TUMOR; FEMALE; GENETIC EPIGENESIS; GENETICS; RISK;

AGE FACTORS; BREAST NEOPLASMS; EPIGENESIS, GENETIC; FEMALE; HUMANS; RISK;

EID: 84908156860     PISSN: 17501911     EISSN: 1750192X     Source Type: Journal    
DOI: 10.2217/epi.14.28     Document Type: Review

References (20)

1. Siegel R, Ma J, Zou Z, Jemal A. Cancer statistics, 2014. CA Cancer J. Clin. 64(1), 9-29 (2014).
2. Desantis C, Ma J, Bryan L, Jemal A. Breast cancer statistics, 2013. CA Cancer J. Clin. 64(1), 52-62 (2014).
3. Stefansson OA, Esteller M. Epigenetic modifications in breast cancer and their role in personalized medicine. Am. J. Pathol. 183(4), 1052-1063 (2013).
4. Issa JP. Aging and epigenetic drift: a vicious cycle. J. Clin. Invest. 124(1), 24-29 (2014).
5. Bell JT, Spector TD. A twin approach to unraveling epigenetics. Trends Genet. 27(3), 116-125 (2011).
6. Martin GM. Stochastic modulations of the pace and patterns of ageing: impacts on quasi-stochastic distributions of multiple geriatric pathologies. Mech. Ageing Dev. 133(4), 107-111 (2012).
7. Huidobro C, Fernandez AF, Fraga MF. Aging epigenetics: causes and consequences. Mol. Aspects Med. 34(4), 765-781 (2013).
8. Fraga MF, Ballestar E, Paz MF et al. Epigenetic differences arise during the lifetime of monozygotic twins. Proc. Natl Acad. Sci. USA 102(30), 10604-10609 (2005).
9. Hervouet E, Cartron PF, Jouvenot M, Delage-Mourroux R. Epigenetic regulation of estrogen signaling in breast cancer. Epigenetics 8(3), 237-245 (2013).
10. Christensen BC, Houseman EA, Marsit CJ et al. Aging and environmental exposures alter tissue-specific DNA methylation dependent upon CpG island context. PLoS Genet. 5(8), e1000602 (2009).
11. Langevin SM, Houseman EA, Christensen BC et al. The influence of aging, environmental exposures and local sequence features on the variation of DNA methylation in blood. Epigenetics 6(7), 908-919 (2011).
12. Bjornsson HT, Sigurdsson MI, Fallin MD et al. Intraindividual change over time in DNA methylation with familial clustering. JAMA 299(24), 2877-2883 (2008).
13. Damaschke NA, Yang B, Bhusari S, Svaren JP, Jarrard DF. Epigenetic susceptibility factors for prostate cancer with aging. Prostate 73(16), 1721-1730 (2013).
14. Horvath S. DNA methylation age of human tissues and cell types. Genome Biol. 14(10), R115 (2013).
15. Hannum G, Guinney J, Zhao L et al. Genome-wide methylation profiles reveal quantitative views of human aging rates. Mol. Cell 49(2), 359-367 (2013).
16. Euhus DM, Bu D, Milchgrub S et al. DNA methylation in benign breast epithelium in relation to age and breast cancer risk. Cancer Epidemiol. Biomarkers Prev. 17(5), 1051-1059 (2008).
17. Toyota M, Ahuja N, Ohe-Toyota M, Herman JG, Baylin SB, Issa JP. CpG island methylator phenotype in colorectal cancer. Proc. Natl Acad. Sci. USA 96(15), 8681-8686 (1999).
18. Johnson KC, Koestler DC, Cheng C, Christensen BC. Age-related DNA methylation in normal breast tissue and its relationship with invasive breast tumor methylation. Epigenetics 9(2), 268-275 (2014).
19. Rakyan VK, Down TA, Maslau S et al. Human agingassociated DNA hypermethylation occurs preferentially at bivalent chromatin domains. Genome Res. 20(4), 434-439 (2010).
20. Bean GR, Ibarra Drendall C, Goldenberg VK et al. Hypermethylation of the breast cancer-associated gene 1 promoter does not predict cytologic atypia or correlate with surrogate end points of breast cancer risk. Cancer Epidemiol. Biomarkers Prev. 16(1), 50-56 (2007).